These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 21786113)
1. Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients. Becker-Schiebe M; Mengs U; Schaefer M; Bulitta M; Hoffmann W Strahlenther Onkol; 2011 Aug; 187(8):485-91. PubMed ID: 21786113 [TBL] [Abstract][Full Text] [Related]
2. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study. Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571 [TBL] [Abstract][Full Text] [Related]
3. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care? Röper B; Kaisig D; Auer F; Mergen E; Molls M Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162 [TBL] [Abstract][Full Text] [Related]
4. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial. Karbasforooshan H; Hosseini S; Elyasi S; Fani Pakdel A; Karimi G Phytother Res; 2019 Feb; 33(2):379-386. PubMed ID: 30479044 [TBL] [Abstract][Full Text] [Related]
5. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams. Ulff E; Maroti M; Serup J; Falkmer U Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771 [TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Togni S; Maramaldi G; Bonetta A; Giacomelli L; Di Pierro F Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1338-44. PubMed ID: 25967706 [TBL] [Abstract][Full Text] [Related]
7. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912 [TBL] [Abstract][Full Text] [Related]
8. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions--results from a randomised blinded trial. Sharp L; Finnilä K; Johansson H; Abrahamsson M; Hatschek T; Bergenmar M Eur J Oncol Nurs; 2013 Aug; 17(4):429-35. PubMed ID: 23245940 [TBL] [Abstract][Full Text] [Related]
9. Topical cream containing nanoparticles with vitamin E to prevent radiodermatitis in women with breast cancer: a clinical trial protocol. Schmidt FMQ; González CVS; Mattar RC; Lopes LB; Dos Santos MF; de Gouveia Santos VLC J Wound Care; 2021 Jun; 30(Sup6):S44-S50. PubMed ID: 34120463 [TBL] [Abstract][Full Text] [Related]
10. Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy. Hoopfer D; Holloway C; Gabos Z; Alidrisi M; Chafe S; Krause B; Lees A; Mehta N; Tankel K; Strickland F; Hanson J; King C; Ghosh S; Severin D Clin Breast Cancer; 2015 Jun; 15(3):181-90.e1-4. PubMed ID: 25619686 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis. Pardo Masferrer J; Murcia Mejía M; Vidal Fernández M; Alvarado Astudillo A; Hernández Armenteros ML; Macías Hernández V; Soto Pérez R; Mirada Ferre A Clin Transl Oncol; 2010 Jan; 12(1):43-8. PubMed ID: 20080470 [TBL] [Abstract][Full Text] [Related]
12. Prevention of cutaneous damages induced by radiotherapy in breast cancer: an institutional experience. Ravo V; Calvanese MG; Di Franco R; Crisci V; Murino P; Manzo R; Morra A; Cammarota F; Muto P Tumori; 2011; 97(6):732-6. PubMed ID: 22322839 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study. Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066 [TBL] [Abstract][Full Text] [Related]
14. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study. Palatty PL; Azmidah A; Rao S; Jayachander D; Thilakchand KR; Rai MP; Haniadka R; Simon P; Ravi R; Jimmy R; D'souza PF; Fayad R; Baliga MS Br J Radiol; 2014 Jun; 87(1038):20130490. PubMed ID: 24694358 [TBL] [Abstract][Full Text] [Related]
15. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V; Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198 [TBL] [Abstract][Full Text] [Related]
16. Photobiomodulation therapy for the management of radiation-induced dermatitis : A single-institution experience of adjuvant radiotherapy in breast cancer patients after breast conserving surgery. Strouthos I; Chatzikonstantinou G; Tselis N; Bon D; Karagiannis E; Zoga E; Ferentinos K; Maximenko J; Nikolettou-Fischer V; Zamboglou N Strahlenther Onkol; 2017 Jun; 193(6):491-498. PubMed ID: 28243723 [TBL] [Abstract][Full Text] [Related]
17. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855 [TBL] [Abstract][Full Text] [Related]
18. Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients. Schmeel LC; Koch D; Stumpf S; Leitzen C; Simon B; Schüller H; Vornholt S; Schoroth F; Müdder T; Röhner F; Garbe S; Schmeel FC; Schild HH; Wilhelm-Buchstab TM Acta Oncol; 2018 Jul; 57(7):908-915. PubMed ID: 29463159 [TBL] [Abstract][Full Text] [Related]
19. Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial. Rahimi A; Mohamad O; Albuquerque K; Kim DWN; Chen D; Thomas K; Wooldridge R; Rivers A; Leitch M; Rao R; Haley B; Ahn C; Garwood D; Spangler A Support Care Cancer; 2020 Mar; 28(3):1481-1489. PubMed ID: 31273506 [TBL] [Abstract][Full Text] [Related]
20. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients. Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]